Literature DB >> 6449756

Plasma exchange and platelet function in Raynaud's phenomenon.

J Zahavi, W A Hamilton, M J O'Reilly, J Leyton, L T Cotton, V V Kakkar.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6449756     DOI： 10.1016/0049-3848(80)90406-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  11 in total

Review 1.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.

Authors:  I A Reilly; L Roy; G A Fitzgerald
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

3.  Treatment of Raynaud's phenomenon with large doses of triiodothyronine: a pilot study.

Authors:  P H Dessein; R F Gledhill
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

4.  The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.

Authors:  J L Francis; O S Roath; V F Challenor; D G Waller
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

5.  A graph-based recovery and decomposition of Swanson's hypothesis using semantic predications.

Authors:  Delroy Cameron; Olivier Bodenreider; Hima Yalamanchili; Tu Danh; Sreeram Vallabhaneni; Krishnaprasad Thirunarayan; Amit P Sheth; Thomas C Rindflesch
Journal:  J Biomed Inform       Date:  2012-09-28       Impact factor: 6.317

6.  Inhibition of human platelet functions by cyclandelate.

Authors:  W E van den Hoven; D W Hall
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Abnormal platelet aggregation in patients with Raynaud's phenomenon.

Authors:  M L Biondi; B Marasini
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

8.  Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.

Authors:  J J Belch; J Cormie; P Newman; M McLaren; J Barbenel; H Capell; P Leiberman; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 9.  Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review.

Authors:  F De Clerck; J M van Nueten; R S Reneman
Journal:  Agents Actions       Date:  1984-12

10.  Context-driven automatic subgraph creation for literature-based discovery.

Authors:  Delroy Cameron; Ramakanth Kavuluru; Thomas C Rindflesch; Amit P Sheth; Krishnaprasad Thirunarayan; Olivier Bodenreider
Journal:  J Biomed Inform       Date:  2015-02-07       Impact factor: 6.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.